Biotechnology
Omicron XBB.1.5 does not have mutations known to make people sicker, WHO says
A man is getting a Covid-19 test at a Covid-19 mobile testing site as people lined up at the Times Square in New York City, on Dec 6, 2021. Tayfun Coskun | Anadolu Agency | Getty Images The omicron XBB.1.5 subvariant does not have any mutations known to make people sicker when they catch the […]
Read More
Watch stay: Nassau County GOP officers simply call on Rep. George Santos to ‘immediately resign’ around campaign lies
(The press conference is scheduled to begin at 11:30 a.m. ET. Please refresh the site if the over online video won’t get started at that time.) Top Republicans in Nassau County, New York, called on GOP Rep. George Santos to right away resign Wednesday for fabricating main details of his resume, blasting the freshman lawmaker […]
Read More
Biden administration extends Covid public health and fitness emergency as really infectious omicron XBB.1.5 spreads
Folks wearing masks stroll subsequent to coronavirus sickness (COVID-19) tests site in New York Metropolis, New York, U.S., December 12, 2022. Eduardo Munoz | Reuters The Biden administration has prolonged the Covid-19 public wellbeing emergency until finally April as a very transmissible omicron subvariant stokes concern that the U.S. may facial area a further wave […]
Read More
Sen. Bernie Sanders urges Moderna not to hike price of Covid-19 vaccines
Sen. Bernie Sanders on Tuesday urged Moderna not to quadruple the price of its Covid-19 vaccine once distribution of the shots moves to the commercial market. In a letter to Moderna CEO Stephane Bancel, Sanders called the price increase “outrageous.” The independent senator from Vermont and incoming chair of the Senate’s health committee said such […]
Read More
Most Alzheimer’s patients would pay up to $26,500 per year for new treatment Leqembi
Few seniors with early Alzheimer’s disease will have access to the new treatment Leqembi due to its high cost and very limited coverage by Medicare. The Food and Drug Administration on Friday granted accelerated approval to Biogen and Eisai’s monoclonal antibody after the treatment appeared to modestly slow the progression of Alzheimer’s disease in clinical […]
Read More
Fda approves Alzheimer’s drug that slowed cognitive decrease in medical demo
MRI picture of mind showing region of Alzheimer affected individual. Getty Illustrations or photos The Food items and Drug Administration on Friday granted accelerated approval for the Alzheimer’s drug lecanemab, formulated by Biogen and the Japanese pharmaceutical firm Eisai. The FDA’s approval will come immediately after scientific trial benefits published in November indicated that lecanemab […]
Read More
Omicron XBB.1.5 is rising in U.S. though revised CDC data shows slower increase than previously reported
The Centers for Disease Control and Prevention on Friday revised downward its estimate of how much the omicron XBB.1.5 subvariant is circulating across the U.S., though it continues to spread at a faster pace than other versions of Covid-19. XBB.1.5 made up 27.6% of sequenced Covid cases nationally for the week ending Jan. 7 compared […]
Read More
CVS and Walgreens will provide mifepristone in pharmacies
Mifepristone (Mifeprex), a single of the two medicines used in a treatment abortion, is exhibited at the Women’s Reproductive Clinic, which supplies authorized medicine abortion expert services, in Santa Teresa, New Mexico, on June 15, 2022. Robyn Beck | AFP | Getty Photographs Walgreens and CVS will promote the abortion pill mifepristone following the Foodstuff […]
Read More
XBB.1.5 omicron subvariant is the most transmissible version of Covid yet, WHO says
XBB.1.5 strain, January 4, 2023, Suqian, Jiangsu, China. CFOTO | Future Publishing | Getty Images The XBB.1.5 omicron subvariant that’s currently dominating the U.S. is the most contagious version of Covid-19 yet, but it doesn’t appear to make people sicker, according to the World Health Organization. Maria Van Kerkhove, the WHO’s Covid-19 technical lead, said […]
Read More
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly
Gilnature | Istock | Getty Images The Covid Omicron XBB.1.5 variant is rapidly becoming dominant in the U.S. because it is highly immune evasive and appears more effective at binding to cells than related subvariants, scientists say. XBB.1.5 now represents about 41% of new cases nationwide in the U.S., nearly doubling in prevalence over the […]
Read More